Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

RETRACTED: Amelioration of osteoporosis by menatetrenone in elderly female Parkinson’s disease patients with vitamin D deficiency

Sato, Y, Honda, Y, Kaji, M, Asoh, T, Hosokawa, K, Kondo, I, Satoh, K · 2002 · Bone

Abstract

Significant reduction in bone mineral density (BMD) occurs in patients with Parkinson's disease (PD), correlating with immobilization and with vitamin D deficiency, and increasing the risk of hip fracture, especially in elderly women. As a biological indicator of compromised vitamin K status, an increased serum concentration of undercarboxylated osteocalcin (Oc) has been associated with reduced BMD in the hip and an increased risk of fracture in otherwise healthy elderly women. We evaluated treatment with vitamin K(2) (menatetrenone; MK-4) in maintaining BMD and reducing the incidence of nonvertebral fractures in elderly female patients with PD. In a random and prospective study of PD patients, 60 received 45 mg of MK-4 daily for 12 months, and the remaining 60 (untreated group) did not. At baseline, patients of both groups showed vitamin D and K(1) deficiencies, high serum levels of ionized calcium, and glutaminic residue (Glu) Oc, and low levels of parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D [1,25-(OH)(2)D], indicating that immobilization-induced hypercalcemia inhibits renal synthesis of 1,25-(OH)(2)D and compensatory PTH secretion. BMD in the second metacarpals increased by 0.9% in the treated group and decreased by 4.3% in the untreated group (p < 0.0001). Vitamin K(2) level increased by 259.8% in the treated group. Correspondingly, significant decreases in Glu Oc and calcium were observed in the treated group, in association with an increase in both PTH and 1,2…

Overview

Integrity signals

Registry

Crossref · 10.1016/s8756-3282(02)00783-4This paper is marked retracted.

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

3 retracted

Show all 33 references

Research works printed but not linked: 1

  1. Orimo, 1992, Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis—A double-blind multicenter comparative study, J Bone Miner Res, 7, S122

Cited by

See all 76

Metadata

Authors
Sato, Y., Honda, Y., Kaji, M., Asoh, T., Hosokawa, K., Kondo, I., & Satoh, K.
Affiliations
  • Kurume University (JP)
  • Social Insurance Futase Hospital (JP)
  • Hirosaki University (JP)
Venue
Bone
Publisher
Elsevier BV
Published
2002-07
Volume
31
Issue
1
Pages
114-118
ISSN
  • 1873-2763 (ISSN-L)
  • 8756-3282
OpenAlex
W2048546795
Cited by
76
References
33
Citations by year
2026: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 6 · 2012: 5
FWCI
3.48
Type
journal article
Language
en
Status
Retracted
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Bone (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
menatetrenone, vitamin K2, Parkinson's disease, osteoporosis, vitamin D deficiency, bone mineral density, hip fracture, non-vertebral fractures, undercarboxylated osteocalcin, immobilization, hypercalcemia, parathyroid hormone, 1,25-dihydroxyvitamin D, older women, retraction
MeSH terms
Aged, Aged, 80 and over, Analysis of Variance, Female, Humans, Osteoporosis, Parkinson Disease, Patients, Prospective Studies, Vitamin D Deficiency, Bone Density, Chi-Square Distribution, Statistics, Nonparametric, Vitamin K 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RETRACTED: Amelioration of osteoporosis by menatetrenone in elderly female Parkinson’s disease patients with vitamin D deficiency. https://app.cochat.ai/papers/10.1016/s8756-3282(02)00783-4
The paper
Sato, Y., Honda, Y., Kaji, M., Asoh, T., Hosokawa, K., Kondo, I., & Satoh, K. (2002). RETRACTED: Amelioration of osteoporosis by menatetrenone in elderly female Parkinson’s disease patients with vitamin D deficiency. Bone. https://doi.org/10.1016/s8756-3282(02)00783-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.